Yellow fever vaccination (Stamaril, France)

Stamaril vaccine (manufactured by Sanofi Pasteur) is aimed for the active immunization against yellow fever for the people traveling to an endemic region, making a transit trip through it or living in it, and also those who travel to any country that requires information on the vaccination upon arrival. Vaccination is also recommended for the people that contact with potentially contaminated materials (for example, laboratory workers).

1 dose of the vaccine (0.5 ml) includes the yellow fever virus, strain 17D-204 (live, attenuated), reared on special pathogen-free chick embryos of not less than 1000 IU.

Adults over the age of 60 should only be vaccinated when it is believed that there is a significant and imminent risk of yellow fever virus contamination.

Routine and emergency vaccination schedules are different. The scheme is prescribed by the doctor who sent a person for the vaccination.

The vaccine is administered subcutaneously; the recommended injection site is the lateral surface of the shoulder in children and adults.

Vaccination does not require any special preparation.